久久久国产一区二区_欧美在线小视频_高清一区二区三区_久久综合久久久_成人久久久久久久久_亚洲精品视

上海非利加實業有限公司Logo

熱門詞: 進口電動溫度調節閥結構圖|進口電動溫度調節閥數據表進口電動高溫調節閥-德國進口電動高溫法蘭調節閥進口電動蒸汽調節閥-德國進口電動蒸汽調節閥

當前位置: 首頁 > 所有品牌 > ISCO
ISCO
ISCO ISCO

美國國際干細胞公司 International Stem Cell Corporation


The Company was founded for the specific purposes of solving key problems in the emerging field of regenerative medicine, cell availability and immune rejection. There are growing numbers of cell transplant therapies that have already been demonstrated to be effective in treating major diseases such as diabetes, liver disease and retinal disease, and many others. What is not available is a reliable, renewable and essentially unlimited source of human cells for use in these transplant procedures. Existing embryonic stem cell lines produce cells that will be difficult to match to the patient’s immune system. Parthenogenetic stem cells can solve both of these problems.

ISCO’s goal is to be the universal supplier of therapeutic cells for:

All developing embryonic stem cell based therapeutic procedures.
 

The medical/scientific research community.

To achieve these goals, ISCO has set three objectives:

To create an abundant source of parthenogenetic stem cells to meet the rapidly growing research and therapeutic demands of regenerative medicine and provide those cells to researchers entering clinical trials.
 

To create stem cell lines from unfertilized eggs, which would have all the benefits of human embryonic stem cells, but are superior in their ability to eliminate or diminish immune rejection in patients.
 

To build a true “Cell Bank” using its existing technology that will allow for on-demand delivery of cells that could be matched to the patient’s own immune system and reduce or eliminate the need for immunosuppressant drugs.

ISCO scientists are confident that we have now made the scientific breakthroughs that will meet these objectives. ISCO has created the world’s first human cell lines through the use of parthenogenesis and has already created the parthenogenetic stem cell line that matches the most common immune type in the US population. These parthenote cell lines will, we believe, be critical to open the pathway to successful stem cell therapy.
 

關于我們客戶服務產品分類法律聲明
主站蜘蛛池模板: 亚洲精品在线免费看 | 精品国产91久久久久 | 久久国产成人精品国产成人亚洲 | 极品美女aⅴ高清在线观看 激情综合久久 | 欧美综合图区亚洲综合图区 | 国产精品视频大全 | 国产全黄a一级毛片视频 | 欧美日韩精品 | 91精品久久久久 | 极品美女国产精品免费一区 | 91精品久久久久久久久久 | 日韩在线第二页 | 国内精品99 | 看全色黄大色大片免费久久久 | 亚洲欧美日韩色 | 一级毛片一级毛片一级级毛片 | 久久国产免费一区 | 日本亚欧乱色视频在线观看 | 久久久久久国产精品免费 | 亚洲精品国产精品乱码不97 | 久草综合网| 午夜视频一区 | 91精品国产色综合久久不卡蜜 | 丝袜国产一区 | 在线观看亚洲一区 | 日韩精品欧美高清区 | 亚洲欧美另类日本 | 国产欧美日韩精品在钱 | 人人添人人澡人人澡人人人爽 | 国产综合成人久久大片91 | 日韩精品 欧美 | 日韩亚洲视频 | 欧美日韩国产高清视频 | 欧美xx在线 | 成人精品一区二区三区 | 99热成人精品国产免国语的 | 精品欧美一区二区三区在线 | 日韩在线视频线视频免费网站 | 免费国产黄网站在线观看视频 | 欧美日韩一区二区在线 | 婷婷综合久久中文字幕蜜桃三电影 |